Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma

Overview of attention for article published in Frontiers in Pharmacology, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,005 followers.

RT @FrontPharmacol: New Research: Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Gliobla…

01 Feb 2022

Reply Repost Favourite

New Research: Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma https://t.co/Zb0S0QJPW9 #pharmacology

01 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.